What are the major opportunities in the Omega 3 Prescription Drugs market? What are the strategies for the Omega 3 Prescription Drugs market?

For detailed insights on the major opportunities and strategies in the Omega 3 Prescription Drugs market, Read More

How does the Omega 3 Prescription Drugs market relate to the overall economy and other similar markets?

For detailed insights on Omega 3 Prescription Drugs's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Omega 3 Prescription Drugs market growth? SWOT analysis of the Omega 3 Prescription Drugs market.

For detailed insights on the key dynamics influencing the Omega 3 Prescription Drugs market growth and SWOT analysis of the Omega 3 Prescription Drugs industry, Read More

Global Omega 3 Prescription Drugs Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report

Omega 3 Prescription Drugs Global Market Report 2025

Name: Omega 3 Prescription Drugs Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Drug Type (Vascepa, Lovaza, Other Type), By Application Type (Hypertriglyceridemia, Other Application Type), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Omega 3 Prescription Drugs Market Overview

• Omega 3 Prescription Drugs market size has reached to $1.61 billion in 2024

• Expected to grow to $2.55 billion in 2029 at a compound annual growth rate (CAGR) of 9.9%

• Growth Driver: Omega-3 Prescription Drug Market Growth Tied To Cardiovascular Disease Surge

• Market Trend: European Commission Approval For Plant-Based Omega-3 Products

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Omega 3 Prescription Drugs Market?

The omega-3 prescription drug lowers the number of triglycerides (a fat-like substance) in the blood and raises the levels of good cholesterol (HDL) in the body. Omega-3 drugs or fatty acids are nutrients obtained from food (or supplements) that assist in developing and maintaining a healthy body and are critical in constructing every cell wall.

The main drug types of omega-3 prescription drugs include vascepa, lovaza, and other types. The vascepa drug is used in adults to reduce the risk of heart attack, stroke, and certain types of heart problems that necessitate hospitalization. Vascepa is an FDA-approved medication used to reduce the risk of certain cardiovascular problems in adults who have high triglyceride levels and two or more additional risk factors for cardiovascular diseases, such as high blood pressure, high cholesterol, or obesity. The application of omega-3 prescription drugs includes hypertriglyceridemia and other application types. The drugs are distributed through hospital pharmacies, retail pharmacies, and online pharmacies.

Omega 3 Prescription Drugs Market 2025 - 2034

What Is The Omega 3 Prescription Drugs Market Size 2025 And Growth Rate?

What Is The Omega 3 Prescription Drugs Market Growth Forecast?

The omega 3 prescription drugs market size is expected to see rapid growth in the next few years. It will grow to $2.55 billion in 2029 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to expanded indications, evolving consumer preferences, targeted health solutions, personalized medicine, clinical evidence expansion. Major trends in the forecast period include personalized health solutions, expanded health conditions, innovative formulations, health supplement popularity, health apps and wearables.

The forecast of 9.9% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade barriers could burden U.S. cardiology practices by driving up prices of high-purity eicosapentaenoic acid and docosahexaenoic acid formulations sourced from Norway and Italy, potentially reducing hypertriglyceridemia treatment options and raising cardiovascular prevention costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Omega 3 Prescription Drugs Market Segmented?

1) By Drug Type: Vascepa, Lovaza, Other Type

2) By Application Type: Hypertriglyceridemia, Other Application Type

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Vascepa: Pure EPA (Eicosapentaenoic Acid) Formulation, Indications For Cardiovascular Risk Reduction

2) By Lovaza: Combination Of EPA And DHA (Docosahexaenoic Acid), Indications For Hypertriglyceridemia Management

3) By Other Types: Epanova (Omega-3 Carboxylic Acids), Omega-3 Formulations In Clinical Trials, Other Prescription Omega-3 Products

Omega 3 Prescription Drugs Market Driver: Omega-3 Prescription Drug Market Growth Tied To Cardiovascular Disease Surge

Rising cases of cardiovascular diseases (CVDs) are expected to contribute to the growth of the omega-3 prescription drug market. Increased blood triglyceride levels (a fatty-like substance) are linked to a higher risk of cardiovascular disorders, and omega-3 supplements aid in regulating and lowering triglyceride levels. For instance, according to the World Health Organization (WHO) report for 2022, cardiovascular diseases (CVDs) remained the leading cause of death worldwide, responsible for around 20.5 million deaths, which is nearly a third of all global fatalities. This represents an increase compared to the previously estimated 121 million CVD-related deaths. Therefore, rising cases of cardiovascular diseases (CVDs) drive the growth of the omega-3 prescription drug market.

Omega 3 Prescription Drugs Market Driver: Obesity's Impact On Omega-3 Drug Market Growth

The growing obese population is expected to contribute to the growth of the omega-3 prescription drug market. Obesity refers to the abnormal or excessive accumulation of fat, which might impair the health of individuals. Omega-3 prescription drug are used for managing specific obesity-related conditions and improving overall health, support weight management efforts. For instance, in March 2022, according to the World Health Organization (WHO), over 1 billion people globally are currently obese (2022), of whom 650 million are adults, 340 million are adolescents, and 39 million are children. By 2025, around 167 million people—adults and children—will become less healthy as they are overweight or obese. Therefore, the growing obese population drives the growth of the omega-3 prescription drug market.

Global Omega 3 Prescription Drugs Market Major Players

Major companies operating in the omega 3 prescription drugs market include Ionis Pharmaceuticals, Sarepta Therapeutics, Alnylam Pharmaceuticals, Wave Life Sciences, Dyno Therapeutics, BioNTech SE, Moderna Therapeutics, Silence Therapeutics, Arrowhead Pharmaceuticals, ProQR Therapeutics, Regulus Therapeutics, Stoke Therapeutics, Editas Medicine, Beam Therapeutics, Miragen Therapeutics, Biogen Inc., Pfizer Inc., GlaxoSmithKline plc, Arbutus Biopharma, Sanofi S.A., Benitec Biopharma, CRISPR Therapeutics, Dicerna Pharmaceuticals, Translate Bio, PepGen Inc., Sirnaomics Inc., Sterna Biologicals, Genevant Sciences, Genzyme Corporation.

Global Omega 3 Prescription Drugs Market Trend: European Commission Approval For Plant-Based Omega-3 Products

New product innovations have emerged as a key trend gaining popularity in the omega-3 prescription drug market. Major companies operating in the manufacturing of omega-3 drugs are focused on developing new product innovations to strengthen their position in the market. For instance, in October 2022, the European Commission gave the green light to plant-based omega-3 products from DSM for fish and animal substitutes throughout the EU. DSM claims that the product enhances plant-based foods' nutritional profile and enables the development of fish products based on animals that will be like current fish products. This omega 3 supplement can be used to enhance the nutritional content of goods without having an adverse effect on the marine ecosystem.

Global Omega 3 Prescription Drugs Market Trend: Innovation In Omega-3 Prescription Drugs With Icosapent Ethyl Capsules Drives Market Growth

Major companies operating in the omega-3 prescription drug market are focusing on product launches, such as capsules, to work by decreasing the number of triglycerides made by the body. Capsules are pharmaceutical or dietary supplement dosage forms consisting of a shell typically made of gelatin or a similar substance enclosing a specific quantity of medication, nutrients, or other active ingredients in a convenient and easily ingestible form. For instance, in March 2023, Hikma Pharmaceuticals, an England-based multinational pharmaceutical company that manufactures generic and in-licensed pharmaceutical products, launched Icosapent Ethyl Capsules, 0.5G, in the US. This is indicated for reducing triglyceride levels in adults with severe hypertriglyceridemia, containing eicosatetraenoic acid (EPA) known for its triglyceride-lowering effects. This launch innovates the market by addressing severe hypertriglyceridemia, meeting the rising demand for pharmaceutical-grade omega-3 products, and aligning with the market's focus on effective therapies for conditions like high triglyceride levels.

Need data on a specific region in this market?

Request Customisation

Omega 3 Prescription Drugs Market Merger And Acquisition: KD Pharma Expands Omega-3 Portfolio with Acquisition of DSM-Firmenich’s MEG-3 Fish Oil Business.

In July 2024, KD Pharma, a Europe-based contract development and manufacturing organization (CDMO) specializing in pharmaceutical and nutritional lipids has acquired DSM-Firmenich's MEG-3 fish oil business, including production facilities in Peru and Canada, along with around 200 employees for an undisclosed amount. This strategic move allows KD Pharma to expand its presence in the food, beverage, dietary supplement, and pharmaceutical markets. DSM-Firmenich, a Europe-based and MEG-3 business are connected to omega-3 products.

Regional Outlook For The Global Omega 3 Prescription Drugs Market

North America was the largest region in the omega 3 prescription drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Omega 3 Prescription Drugs Market?

The omega 3 prescription drugs market consists of sales of EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid). Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Omega 3 Prescription Drugs Industry?

The omega 3 prescription drugs market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the omega 3 prescription drugs industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Omega 3 Prescription Drugs Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$1.75 billion
Revenue Forecast In 2034	$2.55 billion
Growth Rate	CAGR of 9.9% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Drug Type: Vascepa, Lovaza, Other Type 2) By Application Type: Hypertriglyceridemia, Other Application Type 3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy Subsegments: 1) By Vascepa: Pure EPA (Eicosapentaenoic Acid) Formulation, Indications For Cardiovascular Risk Reduction 2) By Lovaza: Combination Of EPA And DHA (Docosahexaenoic Acid), Indications For Hypertriglyceridemia Management 3) By Other Types: Epanova (Omega-3 Carboxylic Acids), Omega-3 Formulations In Clinical Trials, Other Prescription Omega-3 Products
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Ionis Pharmaceuticals, Sarepta Therapeutics, Alnylam Pharmaceuticals, Wave Life Sciences, Dyno Therapeutics, BioNTech SE, Moderna Therapeutics, Silence Therapeutics, Arrowhead Pharmaceuticals, ProQR Therapeutics, Regulus Therapeutics, Stoke Therapeutics, Editas Medicine, Beam Therapeutics, Miragen Therapeutics, Biogen Inc., Pfizer Inc., GlaxoSmithKline plc, Arbutus Biopharma, Sanofi S.A., Benitec Biopharma, CRISPR Therapeutics, Dicerna Pharmaceuticals, Translate Bio, PepGen Inc., Sirnaomics Inc., Sterna Biologicals, Genevant Sciences, Genzyme Corporation.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Omega 3 Prescription Drugs Market Characteristics

3. Omega 3 Prescription Drugs Market Trends And Strategies

4. Omega 3 Prescription Drugs Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Omega 3 Prescription Drugs Growth Analysis And Strategic Analysis Framework

5.1. Global Omega 3 Prescription Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Omega 3 Prescription Drugs Market Growth Rate Analysis

5.4. Global Omega 3 Prescription Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Omega 3 Prescription Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Omega 3 Prescription Drugs Total Addressable Market (TAM)

6. Omega 3 Prescription Drugs Market Segmentation

6.1. Global Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Vascepa

Lovaza

Other Type

6.2. Global Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hypertriglyceridemia

Other Application Type

6.3. Global Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

6.4. Global Omega 3 Prescription Drugs Market, Sub-Segmentation Of Vascepa, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pure EPA (Eicosapentaenoic Acid) Formulation

Indications For Cardiovascular Risk Reduction

6.5. Global Omega 3 Prescription Drugs Market, Sub-Segmentation Of Lovaza, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Combination Of EPA And DHA (Docosahexaenoic Acid)

Indications For Hypertriglyceridemia Management

6.6. Global Omega 3 Prescription Drugs Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Epanova (Omega-3 Carboxylic Acids)

Omega-3 Formulations In Clinical Trials

Other Prescription Omega-3 Products

7. Omega 3 Prescription Drugs Market Regional And Country Analysis

7.1. Global Omega 3 Prescription Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Omega 3 Prescription Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Omega 3 Prescription Drugs Market

8.1. Asia-Pacific Omega 3 Prescription Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Omega 3 Prescription Drugs Market

9.1. China Omega 3 Prescription Drugs Market Overview

9.2. China Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Omega 3 Prescription Drugs Market

10.1. India Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Omega 3 Prescription Drugs Market

11.1. Japan Omega 3 Prescription Drugs Market Overview

11.2. Japan Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Omega 3 Prescription Drugs Market

12.1. Australia Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Omega 3 Prescription Drugs Market

13.1. Indonesia Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Omega 3 Prescription Drugs Market

14.1. South Korea Omega 3 Prescription Drugs Market Overview

14.2. South Korea Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Omega 3 Prescription Drugs Market

15.1. Western Europe Omega 3 Prescription Drugs Market Overview

15.2. Western Europe Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Omega 3 Prescription Drugs Market

16.1. UK Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Omega 3 Prescription Drugs Market

17.1. Germany Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Omega 3 Prescription Drugs Market

18.1. France Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Omega 3 Prescription Drugs Market

19.1. Italy Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Omega 3 Prescription Drugs Market

20.1. Spain Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Omega 3 Prescription Drugs Market

21.1. Eastern Europe Omega 3 Prescription Drugs Market Overview

21.2. Eastern Europe Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Omega 3 Prescription Drugs Market

22.1. Russia Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Omega 3 Prescription Drugs Market

23.1. North America Omega 3 Prescription Drugs Market Overview

23.2. North America Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Omega 3 Prescription Drugs Market

24.1. USA Omega 3 Prescription Drugs Market Overview

24.2. USA Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Omega 3 Prescription Drugs Market

25.1. Canada Omega 3 Prescription Drugs Market Overview

25.2. Canada Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Omega 3 Prescription Drugs Market

26.1. South America Omega 3 Prescription Drugs Market Overview

26.2. South America Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Omega 3 Prescription Drugs Market

27.1. Brazil Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Omega 3 Prescription Drugs Market

28.1. Middle East Omega 3 Prescription Drugs Market Overview

28.2. Middle East Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Omega 3 Prescription Drugs Market

29.1. Africa Omega 3 Prescription Drugs Market Overview

29.2. Africa Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Omega 3 Prescription Drugs Market Competitive Landscape And Company Profiles

30.1. Omega 3 Prescription Drugs Market Competitive Landscape

30.2. Omega 3 Prescription Drugs Market Company Profiles

30.2.1. Ionis Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Sarepta Therapeutics Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Alnylam Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Wave Life Sciences Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Dyno Therapeutics Overview, Products and Services, Strategy and Financial Analysis

31. Omega 3 Prescription Drugs Market Other Major And Innovative Companies

31.1. BioNTech SE

31.2. Moderna Therapeutics

31.3. Silence Therapeutics

31.4. Arrowhead Pharmaceuticals

31.5. ProQR Therapeutics

31.6. Regulus Therapeutics

31.7. Stoke Therapeutics

31.8. Editas Medicine

31.9. Beam Therapeutics

31.10. Miragen Therapeutics

31.11. Biogen Inc.

31.12. Pfizer Inc.

31.13. GlaxoSmithKline plc

31.14. Arbutus Biopharma

31.15. Sanofi S.A.

32. Global Omega 3 Prescription Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Omega 3 Prescription Drugs Market

34. Recent Developments In The Omega 3 Prescription Drugs Market

35. Omega 3 Prescription Drugs Market High Potential Countries, Segments and Strategies

35.1 Omega 3 Prescription Drugs Market In 2029 - Countries Offering Most New Opportunities

35.2 Omega 3 Prescription Drugs Market In 2029 - Segments Offering Most New Opportunities

35.3 Omega 3 Prescription Drugs Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Omega 3 Prescription Drugs Market, Sub-Segmentation Of Vascepa, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Omega 3 Prescription Drugs Market, Sub-Segmentation Of Lovaza, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Omega 3 Prescription Drugs Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Omega 3 Prescription Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Omega 3 Prescription Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Indonesia, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: South Korea, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Western Europe, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: UK, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Germany, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: France, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Italy, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Spain, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Eastern Europe, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Russia, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: North America, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: USA, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: Canada, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: South America, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Brazil, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Middle East, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Africa, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Ionis Pharmaceuticals Financial Performance

Table 78: Sarepta Therapeutics Financial Performance

Table 79: Alnylam Pharmaceuticals Financial Performance

Table 80: Wave Life Sciences Financial Performance

Table 81: Dyno Therapeutics Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Omega 3 Prescription Drugs Market, Sub-Segmentation Of Vascepa, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Omega 3 Prescription Drugs Market, Sub-Segmentation Of Lovaza, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Omega 3 Prescription Drugs Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Omega 3 Prescription Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Omega 3 Prescription Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Indonesia, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: South Korea, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Western Europe, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: UK, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Germany, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: France, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Italy, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Spain, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Eastern Europe, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Russia, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: North America, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: USA, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: Canada, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: South America, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Brazil, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Middle East, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Africa, Omega 3 Prescription Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Omega 3 Prescription Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Omega 3 Prescription Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Ionis Pharmaceuticals Financial Performance

Figure 78: Sarepta Therapeutics Financial Performance

Figure 79: Alnylam Pharmaceuticals Financial Performance

Figure 80: Wave Life Sciences Financial Performance

Figure 81: Dyno Therapeutics Financial Performance

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Outdoor Kitchen Appliances Market 2023 – By Product (Cooking Fixtures, Islands And Storage Units, Refrigeration Units, Rangehoods, Sinks And Faucets, Other Products), By Distribution (Offline, Online), By Application (Re...

View Report

Cardiovascular Drugs Global Market Report 2022 – By Type (Anti-Hypertensive Drugs, Hypolipidemics, Anti Thrombotics, Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrhythmic And Anti-Anginal Dru...

View Report

Endoscope Reprocessing Global Market Report 2025 – By Type (Flexible, Rigid), By Product (High-Level Disinfectants and Test Strips, Other Products), By End-User (Hospitals, Ambulatory Surgical Centers and Clinics, Other ...

View Report

Cathode Materials Global Market Report 2025 – By Material (Lithium Cobalt Oxide or Lithium Cobaltate, Lithium Manganese Oxide or Spinel or Lithium Manganate, Lithium Iron Phosphate or Lithium Nickel Manganese Cobalt (NMC...

View Report

Pressure Ulcer Detection Device Global Market Report 2025 – By Product (In-Shoe Sensor, Surface Electrode, SEM (Skin And Tissue Assessment Monitoring Scanner) Scanner, Pressure Measuring Mattress), By Application (Stage ...

View Report

Docks Construction Global Market Report 2025 – By Material (Wood, Metal, Plastic And Composites, Concrete ), By Operation (Conventional, Automatic), By Application (Residential, Commercial, Industrial, Institutional) – I...

View Report

Docks Construction Global Market Report 2025 – By Material (Wood, Metal, Plastic And Composites, Concrete ), By Operation (Conventional, Automatic), By Application (Residential, Commercial, Industrial, Institutional) – I...

View Report

eVTOL Aircraft Market 2023 – By Lift Technology (Vectored Thrust, Multirotor, Lift Plus Cruise), By Propulsion Type (Fully Electric, Hybrid Electric, Hydrogen Electric), By Mode Of Operation (Autonomous, Cement Industry,...

View Report

Frequently Asked Questions

What is the definition of the Omega 3 Prescription Drugs market?

How will the Omega 3 Prescription Drugs market drivers and restraints affect the market dynamics? What forces will shape the Omega 3 Prescription Drugs industry going forward?

The market major growth driver - Omega-3 Prescription Drug Market Growth Tied To Cardiovascular Disease Surge. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Omega 3 Prescription Drugs market?

The omega 3 prescription drugs market size has grown strongly in recent years. It will grow from $1.61 billion in 2024 to $1.75 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to health awareness, clinical research, cardiovascular health emphasis, medical recommendations, chronic diseases management. The omega 3 prescription drugs market size is expected to see strong growth in the next few years. It will grow to " $2.55 billion in 2029 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to expanded indications, evolving consumer preferences, targeted health solutions, personalized medicine, clinical evidence expansion. Major trends in the forecast period include personalized health solutions, expanded health conditions, innovative formulations, health supplement popularity, health apps and wearables. For further insights on this market, request a sample here

How is the Omega 3 Prescription Drugs market segmented?

The omega 3 prescription drugs market covered in this report is segmented –
1) By Drug Type: Vascepa, Lovaza, Other Type
2) By Application Type: Hypertriglyceridemia, Other Application Type
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy Subsegments:
1) By Vascepa: Pure EPA (Eicosapentaenoic Acid) Formulation, Indications For Cardiovascular Risk Reduction
2) By Lovaza: Combination Of EPA And DHA (Docosahexaenoic Acid), Indications For Hypertriglyceridemia Management
3) By Other Types: Epanova (Omega-3 Carboxylic Acids), Omega-3 Formulations In Clinical Trials, Other Prescription Omega-3 Products For further insights on this market, request a sample here

Which region has the largest share of the Omega 3 Prescription Drugs market? What are the other regions covered in the report?

North America was the largest region in the omega 3 prescription drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the omega 3 prescription drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Omega 3 Prescription Drugs market?

What are the key trends in the Omega 3 Prescription Drugs market?

Major trends in this market include European Commission Approval For Plant-Based Omega-3 Products. For further insights on this market, request a sample here.

Book your 30 minutes free consultation with our research experts

Omega 3 Prescription Drugs Global Market Report 2025

By Drug Type (Vascepa, Lovaza, Other Type), By Application Type (Hypertriglyceridemia, Other Application Type), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Omega 3 Prescription Drugs Market Overview

What Is Covered Under Omega 3 Prescription Drugs Market?

What Is The Omega 3 Prescription Drugs Market Size 2025 And Growth Rate?

What Is The Omega 3 Prescription Drugs Market Growth Forecast?

What’s The Trade War Impact On Pharmaceuticals Industry?

How Is The Omega 3 Prescription Drugs Market Segmented?

Omega 3 Prescription Drugs Market Driver: Omega-3 Prescription Drug Market Growth Tied To Cardiovascular Disease Surge

Omega 3 Prescription Drugs Market Driver: Obesity's Impact On Omega-3 Drug Market Growth

Global Omega 3 Prescription Drugs Market Major Players

Global Omega 3 Prescription Drugs Market Trend: European Commission Approval For Plant-Based Omega-3 Products

Global Omega 3 Prescription Drugs Market Trend: Innovation In Omega-3 Prescription Drugs With Icosapent Ethyl Capsules Drives Market Growth

Omega 3 Prescription Drugs Market Merger And Acquisition: KD Pharma Expands Omega-3 Portfolio with Acquisition of DSM-Firmenich’s MEG-3 Fish Oil Business.

Regional Outlook For The Global Omega 3 Prescription Drugs Market

What Defines the Omega 3 Prescription Drugs Market?

How is Market Value Defined and Measured?

What is the Market Assessment and Strategic Outlook for the Omega 3 Prescription Drugs Industry?

Omega 3 Prescription Drugs Market Report Forecast Analysis

Table Of Contents

List Of Tables

List Of Figures

Frequently Asked Questions